Dow 10-Q 2024-09-30
DOW · CIK 1751788 · Form 10-Q · Period ended September 30, 2024 · Filed October 25, 2024
Revenue rose 1.4% to $10.9 billion. Net income was $214 million.
8 sections, 233K characters. Original on sec.gov · ·
| Measure | Quarter ended Sep 30, 2024 | Quarter ended Sep 30, 2023 | Change |
|---|---|---|---|
| Revenue | $10.9B | $10.7B | +1.4% |
| Net income | $214M | $302M | -29.1% |
| Diluted EPS | $0.30 | $0.42 | -28.6% |
| Cash and equivalents | $2.88B | n/a | n/a |
From the XBRL facts tagged to this filing; both columns are as reported in this filing.
Cover and table of contents
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended September 30, 2024
or
☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from to

| Commission File Number | Exact Name of Registrant as Specified in its Charter, Principal Office Address and Telephone Number | State of Incorporation or Organization | I.R.S. Employer Identification No. | ||||||||
| 001-38646 | Dow Inc. | Delaware | 30-1128146 | ||||||||
| 2211 H.H. Dow Way, Midland, MI 48674 | |||||||||||
| (989) 636-1000 | |||||||||||
| 001-03433 | The Dow Chemical Company | Delaware | 38-1285128 | ||||||||
| 2211 H.H. Dow Way, Midland, MI 48674 | |||||||||||
| (989) 636-1000 |
Securities registered pursuant to Section 12(b) of the Act:
| Registrant | Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||||
| Dow Inc. | Common Stock, par value $0.01 per share | DOW | New York Stock Exchange | ||||||||
| The Dow Chemical Company | 0.500% Notes due March 15, 2027 | DOW/27 | New York Stock Exchange | ||||||||
| The Dow Chemical Company | 1.125% Notes due March 15, 2032 | DOW/32 | New York Stock Exchange | ||||||||
| The Dow Chemical Company | 1.875% Notes due March 15, 2040 | DOW/40 | New York Stock Exchange | ||||||||
| The Dow Chemical Company | 4.625% Notes due October 1, 2044 | DOW/44 | New York Stock Exchange |
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
| Dow Inc. | ☑ | Yes | ☐ | No | The Dow Chemical Company | ☑ | Yes | ☐ | No |
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).
| Dow Inc. | ☑ | Yes | ☐ | No | The Dow Chemical Company | ☑ | Yes | ☐ | No |
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and "emerging growth company" in Rule 12b-2 of the Exchange Act.
| Dow Inc. | Large accelerated filer | ☑ | Accelerated filer | ☐ | Non-accelerated filer | ☐ | Smaller reporting company | ☐ | Emerging growth company | ☐ | ||||||||||||||||||||||
| The Dow Chemical Company | Large accelerated filer | ☐ | Accelerated filer | ☐ | Non-accelerated filer | ☑ | Smaller reporting company | ☐ | Emerging growth company | ☐ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
| Dow Inc. | ☐ | The Dow Chemical Company | ☐ |
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
| Dow Inc. | ☐ | Yes | ☑ | No | The Dow Chemical Company | ☐ | Yes | ☑ | No |
Dow Inc. had 700,091,690 shares of common stock, $0.01 par value, outstanding at September 30, 2024. The Dow Chemical Company had 100 shares of common stock, $0.01 par value, outstanding at September 30, 2024, all of which were held by the registrant’s parent, Dow Inc.
The Dow Chemical Company meets the conditions set forth in General Instruction H(1)(a) and (b) for Form 10-Q and therefore is filing this form with a reduced disclosure format.
Dow Inc. and Subsidiaries
The Dow Chemical Company and Subsidiaries
QUARTERLY REPORT ON FORM 10-Q
For the quarterly period ended September 30, 2024
TABLE OF CONTENTS
| Dow Inc. and Subsidiaries The Dow Chemical Company and Subsidiaries |
This Quarterly Report on Form 10-Q is a combined report being filed by Dow Inc. and The Dow Chemical Company and its consolidated subsidiaries (“TDCC” and together with Dow Inc., “Dow” or the "Company") due to the parent/subsidiary relationship between Dow Inc. and TDCC. The information reflected in the report is equally applicable to both Dow Inc. and TDCC, except where otherwise noted. Each of Dow Inc. and TDCC is filing information in this report on its own behalf and neither company makes any representation to the information relating to the other company.
CAUTIONARY STATEMENT ABOUT FORWARD-LOOKING STATEMENTS
Certain statements in this report are “forward-looking statements” within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements often address expected future business and financial performance, financial condition, and other matters, and often contain words or phrases such as “anticipate,” “believe,” “estimate,” “expect,” “intend,” “may,” “opportunity,” “outlook,” “plan,” “project,” “seek,” “should,” “strategy,” “target,” “will,” “will be,” “will continue,” “will likely result,” “would” and similar expressions, and variations or negatives of these words or phrases.
Forward-looking statements are based on current assumptions and expectations of future events that are subject to risks, uncertainties and other factors that are beyond Dow’s control, which may cause actual results to differ materially from those projected, anticipated or implied in the forward-looking statements and speak only as of the date the statements were made. These factors include, but are not limited to: sales of Dow’s products; Dow’s expenses, future revenues and profitability; any global and regional economic impacts of a pandemic or other public health-related risks and events on Dow’s business; any sanctions, export restrictions, supply chain disruptions or increased economic uncertainty related to the ongoing conflicts between Russia and Ukraine and in the Middle East; capital requirements and need for and availability of financing; unexpected barriers in the development of technology, including with respect to Dow's contemplated capital and operating projects; Dow's ability to realize its commitment to carbon neutrality on the contemplated timeframe, including the completion and success of its integrated ethylene cracker and derivatives facility in Alberta, Canada; size of the markets for Dow’s products and services and ability to compete in such markets; failure to develop and market new products and optimally manage product life cycles; the rate and degree of market acceptance of Dow’s products; significant litigation and environmental matters and related contingencies and unexpected expenses; the success of competing technologies that are or may become available; the ability to protect Dow’s intellectual property in the United States and abroad; developments related to contemplated restructuring activities and proposed divestitures or acquisitions such as workforce reduction, manufacturing facility and/or asset closure and related exit and disposal activities, and the benefits and costs associated with each of the foregoing; fluctuations in energy and raw material prices; management of process safety and product stewardship; changes in relationships with Dow’s significant customers and suppliers; changes in public sentiment and political leadership; increased concerns about plastics in the environment and lack of a circular economy for plastics at scale; changes in consumer preferences and demand; changes in laws and regulations, political conditions or industry development; global economic and capital markets conditions, such as inflation, market uncertainty, interest and currency exchange rates, and equity and commodity prices; business, logistics, and supply disruptions; security threats, such as acts of sabotage, terrorism or war, including the ongoing conflicts between Russia and Ukraine and in the Middle East; weather events and natural disasters; disruptions in Dow’s information technology networks and systems, including the impact of cyberattacks; and risks related to Dow’s separation from DowDuPont Inc. such as Dow’s obligation to indemnify DuPont de Nemours, Inc. and/or Corteva, Inc. for certain liabilities.
Where, in any forward-looking statement, an expectation or belief as to future results or events is expressed, such expectation or belief is based on the current plans and expectations of management and expressed in good faith and believed to have a reasonable basis, but there can be no assurance that the expectation or belief will result or be achieved or accomplished. A detailed discussion of principal risks and uncertainties which may cause actual results and events to differ materially from such forward-looking statements is included in the section titled “Risk Factors” contained in Part II, Item 1A of this Quarterly Report on Form 10-Q and in Part I, Item 1A of the Company’s Annual Report on Form 10-K for the year ended December 31, 2023. These are not the only risks and uncertainties that Dow faces. There may be other risks and uncertainties that Dow is unable to identify at this time or that Dow does not currently expect to have a material impact on its business. If any of those risks or uncertainties develops into an actual event, it could have a material adverse effect on Dow’s business. Dow Inc. and TDCC assume no obligation to update or revise publicly any forward-looking statements whether because of new information, future events, or otherwise, except as required by securities and other applicable laws.
Dow's website and its content are not deemed incorporated by reference into this report.
| PART I – FINANCIAL INFORMATION |
Item 1. FINANCIAL STATEMENTS
Dow Inc. and Subsidiaries
Consolidated Statements of Income
| Three Months Ended | Nine Months Ended | |||||||||||||
| In millions, except per share amounts (Unaudited) | Sep 30, 2024 | Sep 30, 2023 | Sep 30, 2024 | Sep 30, 2023 | ||||||||||
| Net sales | $ | 10,879 | $ | 10,730 | $ | 32,559 | $ | 34,001 | ||||||
| Cost of sales | 9,809 | 9,592 | 28,888 | 30,096 | ||||||||||
| Research and development expenses | 208 | 197 | 608 | 616 | ||||||||||
| Selling, general and administrative expenses | 396 | 380 | 1,228 | 1,216 | ||||||||||
| Amortization of intangibles | 76 | 81 | 234 | 243 | ||||||||||
| Restructuring and asset related charges - net | 24 | — | 69 | 549 | ||||||||||
| Equity in earnings (losses) of nonconsolidated affiliates | 2 | (7) | 45 | (112) | ||||||||||
| Sundry income (expense) - net | 119 | 92 | 256 | 202 | ||||||||||
| Interest income | 36 | 44 | 143 | 186 | ||||||||||
| Interest expense and amortization of debt discount | 199 | 192 | 595 | 549 | ||||||||||
| Income before income taxes | 324 | 417 | 1,381 | 1,008 | ||||||||||
| Provision for income taxes | 84 | 90 | 145 | 253 | ||||||||||
| Net income | 240 | 327 | 1,236 | 755 | ||||||||||
| Net income attributable to noncontrolling interests | 26 | 25 | 67 | 61 | ||||||||||
| Net income available for Dow Inc. common stockholders | $ | 214 | $ | 302 | $ | 1,169 | $ | 694 | ||||||
| Per common share data: | ||||||||||||||
| Earnings per common share - basic | $ | 0.30 | $ | 0.43 | $ | 1.65 | $ | 0.97 | ||||||
| Earnings per common share - diluted | $ | 0.30 | $ | 0.42 | $ | 1.65 | $ | 0.97 | ||||||
| Weighted-average common shares outstanding - basic | 702.3 | 704.0 | 703.5 | 706.4 | ||||||||||
| Weighted-average common shares outstanding - diluted | 703.6 | 707.5 | 704.9 | 709.7 | ||||||||||
| Depreciation | $ | 501 | $ | 484 | $ | 1,470 | $ | 1,443 | ||||||
| Capital expenditures | $ | 736 | $ | 597 | $ | 2,173 | $ | 1,598 |
See Notes to the Consolidated Financial Statements.
Dow Inc. and Subsidiaries
Consolidated Statements of Comprehensive Income
| Three Months Ended | Nine Months Ended | |||||||||||||
| In millions (Unaudited) | Sep 30, 2024 | Sep 30, 2023 | Sep 30, 2024 | Sep 30, 2023 | ||||||||||
| Net income | $ | 240 | $ | 327 | $ | 1,236 | $ | 755 | ||||||
| Other comprehensive income (loss), net of tax | ||||||||||||||
| Unrealized gains (losses) on investments | 34 | (20) | 89 | 72 | ||||||||||
| Cumulative translation adjustments | 199 | (147) | 34 | (149) | ||||||||||
| Pension and other postretirement benefit plans | 18 | (2) | 52 | — | ||||||||||
| Derivative instruments | 31 | (25) | 3 | (45) | ||||||||||
| Total other comprehensive income (loss) | 282 | (194) | 178 | (122) | ||||||||||
| Comprehensive income | 522 | 133 | 1,414 | 633 | ||||||||||
| Comprehensive income attributable to noncontrolling interests, net of tax | 26 | 25 | 67 | 61 | ||||||||||
| Comprehensive income attributable to Dow Inc. | $ | 496 | $ | 108 | $ | 1,347 | $ | 572 |
See Notes to the Consolidated Financial Statements.
Dow Inc. and Subsidiaries
Consolidated Balance Sheets
| In millions, except share amounts (Unaudited) | Sep 30, 2024 | Dec 31, 2023 | ||||||
| Assets | ||||||||
| Current Assets | ||||||||
| Cash and cash equivalents | $ | 2,883 | $ | 2,987 | ||||
| Accounts and notes receivable: | ||||||||
| Trade (net of allowance for doubtful receivables - 2024: $111; 2023: $81) | 5,380 | 4,718 | ||||||
| Other | 1,936 | 1,896 | ||||||
| Inventories | 6,741 | 6,076 | ||||||
| Other current assets | 1,037 | 1,937 | ||||||
| Total current assets | 17,977 | 17,614 | ||||||
| Investments | ||||||||
| Investment in nonconsolidated affiliates | 1,303 | 1,267 | ||||||
| Other investments (investments carried at fair value - 2024: $2,135; 2023: $1,877) | 2,854 | 2,740 | ||||||
| Noncurrent receivables | 525 | 438 | ||||||
| Total investments | 4,682 | 4,445 | ||||||
| Property | ||||||||
| Property | 62,642 | 60,203 | ||||||
| Less: Accumulated depreciation | 40,549 | 39,137 | ||||||
| Net property | 22,093 | 21,066 | ||||||
| Other Assets | ||||||||
| Goodwill | 8,684 | 8,641 | ||||||
| Other intangible assets (net of accumulated amortization - 2024: $5,645; 2023: $5,374) | 1,840 | 2,072 | ||||||
| Operating lease right-of-use assets | 1,301 | 1,320 | ||||||
| Deferred income tax assets | 1,526 | 1,486 | ||||||
| Deferred charges and other assets | 1,286 | 1,323 | ||||||
| Total other assets | 14,637 | 14,842 | ||||||
| Total Assets | $ | 59,389 | $ | 57,967 | ||||
| Liabilities and Equity | ||||||||
| Current Liabilities | ||||||||
| Notes payable | $ | 111 | $ | 62 | ||||
| Long-term debt due within one year | 296 | 117 | ||||||
| Accounts payable: | ||||||||
| Trade | 5,093 | 4,529 | ||||||
| Other | 1,955 | 1,797 | ||||||
| Operating lease liabilities - current | 316 | 329 | ||||||
| Income taxes payable | 257 | 419 | ||||||
| Accrued and other current liabilities | 2,799 | 2,704 | ||||||
| Total current liabilities | 10,827 | 9,957 | ||||||
| Long-Term Debt | 16,164 | 14,907 | ||||||
| Other Noncurrent Liabilities | ||||||||
| Deferred income tax liabilities | 397 | 399 | ||||||
| Pension and other postretirement benefits - noncurrent | 4,689 | 4,932 | ||||||
| Asbestos-related liabilities - noncurrent | 727 | 788 | ||||||
| Operating lease liabilities - noncurrent | 1,023 | 1,032 | ||||||
| Other noncurrent obligations | 6,721 | 6,844 | ||||||
| Total other noncurrent liabilities | 13,557 | 13,995 | ||||||
| Stockholders’ Equity | ||||||||
| Common stock (authorized 5,000,000,000 shares of $0.01 par value each; issued 2024: 782,047,707 shares; 2023: 778,595,514 shares) | 8 | 8 | ||||||
| Additional paid-in capital | 9,055 | 8,880 | ||||||
| Retained earnings | 21,459 | 21,774 | ||||||
| Accumulated other comprehensive loss | (7,503) | (7,681) | ||||||
| Treasury stock at cost (2024: 81,956,017 shares; 2023: 76,302,081 shares) | (4,708) | (4,374) | ||||||
| Dow Inc.’s stockholders’ equity | 18,311 | 18,607 | ||||||
| Noncontrolling interests |
Showing the first 8K of 139K characters. Open the full section
Item 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.
This Quarterly Report on Form 10-Q is a combined report being filed by Dow Inc. and The Dow Chemical Company and its consolidated subsidiaries (“TDCC” and together with Dow Inc., “Dow” or the "Company") due to the parent/subsidiary relationship between Dow Inc. and TDCC. The information reflected in the report is equally applicable to both Dow Inc. and TDCC, except where otherwise noted. Each of Dow Inc. and TDCC is filing information in this report on its own behalf and neither company makes any representation to the information relating to the other company.
Pursuant to General Instruction H(1)(a) and (b) for Form 10-Q "Omission of Information by Certain Wholly-Owned Subsidiaries," TDCC is filing this Form 10-Q with a reduced disclosure format.
Except as otherwise indicated by the context, the term "Union Carbide" means Union Carbide Corporation and the term "Dow Silicones" means Dow Silicones Corporation, both wholly owned subsidiaries of the Company. Additionally, the term "EMEAI" refers to the geographic region of Europe, Middle East, Africa and India.
Dow's website and its content are not deemed incorporated by reference into this report.
OUTLOOK
The Company continues to operate with discipline as it capitalizes on areas of demand strength and leverages its global scale and advantaged cost positions. As cycle dynamics improve, the Company remains well-positioned to enable higher returns to shareholders. The Company's financial strength will continue to support its counter-cyclical growth investments, which are focused on higher-value businesses and regions, particularly where demand is resilient and the Company has a competitive cost advantage. Altogether, these investments are expected to deliver more than $3 billion in underlying earnings to the Company by 2030.
OVERVIEW
The following is a summary of the results for the three months ended September 30, 2024:
-
The Company reported net sales in the third quarter of 2024 of $10.9 billion, up 1 percent from $10.7 billion in the third quarter of 2023, and mixed by operating segment; Packaging & Specialty Plastics (up 1 percent), Industrial Intermediates & Infrastructure (down 2 percent) and Performance Materials & Coatings (up 4 percent). Net sales increased in the U.S. & Canada and EMEAI (both up 5 percent), partially offset by decreases in Asia Pacific (down 9 percent) and Latin America (down 2 percent).
-
Volume increased 1 percent compared with the third quarter of 2023 and was mixed by operating segment; Packaging & Specialty Plastics (flat), Industrial Intermediates & Infrastructure (down 2 percent) and Performance Materials & Coatings (up 5 percent). Volume increased in the U.S. & Canada and EMEAI (both up 3 percent), decreased in Asia Pacific (down 6 percent) and was flat in Latin America.
-
Local price was flat compared with the third quarter of 2023, and mixed by operating segment; Packaging & Specialty Plastics (up 1 percent), Industrial Intermediates & Infrastructure (flat) and Performance Materials & Coatings (down 1 percent). Local price increased in the U.S. & Canada and EMEAI (both up 2 percent) and decreased in Asia Pacific and Latin America (both down 2 percent).
*•*Equity in earnings of nonconsolidated affiliates was $2 million in the third quarter of 2024, compared with equity in losses of nonconsolidated affiliates of $7 million in the third quarter of 2023, primarily due to improved results at the Company's Kuwait joint ventures, partially offset by lower results at the Company's Thai and Sadara joint ventures.
-
Net income available for Dow Inc. and TDCC common stockholder(s) was $214 million and $224 million, respectively, in the third quarter of 2024, compared with $302 million and $285 million, respectively, in the third quarter of 2023. Earnings per share for Dow Inc. was $0.30 in the third quarter of 2024, compared with $0.42 per share in the third quarter of 2023.
-
Cash provided by operating activities - continuing operations was $800 million in the third quarter of 2024, down $858 million compared with the third quarter of 2023. Cash provided by operating activities - continuing operations was down $32 million compared with the second quarter of 2024.
-
Dow Inc. repurchased $94 million of the Company's common stock in the third quarter of 2024.
-
On July 1, 2024, Fitch Ratings affirmed TDCC's BBB+ and F1 rating, and affirmed its outlook of stable. Also on July 1, 2024, Standard & Poor's affirmed TDCC's BBB and A-2 rating, and affirmed its outlook of stable.
-
On August 1, 2024, the Company acquired Circulus Holdings, PBLLC, a U.S. mechanical recycling company that converts plastic waste into post-consumer resin, for approximately $130 million.
-
On August 6, 2024, Moody's Ratings affirmed TDCC's Baa1 and P-2 rating, and affirmed its outlook of stable.
-
On August 14, 2024, Dow Inc. announced that its Board declared a dividend of $0.70 per share, payable on September 13, 2024, to shareholders of record as of August 30, 2024.
In addition, the following events occurred subsequent to the third quarter of 2024:
-
On October 10, 2024, Dow Inc. announced that its Board declared a dividend of $0.70 per share, payable on December 13, 2024, to shareholders of record as of November 29, 2024.
-
On October 24, 2024, the Company announced that it will complete a strategic review of select assets in Europe, primarily certain polyurethanes assets within the Industrial Intermediates & Infrastructure segment, as part of an effort to continue to optimize its global asset footprint.
RESULTS OF OPERATIONS
Net Sales
The following tables summarize net sales and sales variances by operating segment and geographic region from the prior year:
| Summary of Sales Results | Three Months Ended | Nine Months Ended | ||||||||||||
| In millions | Sep 30, 2024 | Sep 30, 2023 | Sep 30, 2024 | Sep 30, 2023 | ||||||||||
| Net sales | $ | 10,879 | $ | 10,730 | $ | 32,559 | $ | 34,001 |
| Sales Variances by Operating Segment and Geographic Region | Three Months Ended Sep 30, 2024 | Nine Months Ended Sep 30, 2024 | ||||||||||||||||||||||||
| Local Price & Product Mix | Currency | Volume | Total | Local Price & Product Mix | Currency | Volume | Total | |||||||||||||||||||
| Percentage change from prior year | ||||||||||||||||||||||||||
| Packaging & Specialty Plastics | 1 | % | — | % | — | % | 1 | % | (4) | % | — | % | (2) | % | (6) | % | ||||||||||
| Industrial Intermediates & Infrastructure | — | — | (2) | (2) | (7) | (1) | 1 | (7) | ||||||||||||||||||
| Performance Materials & Coatings | (1) | — | 5 | 4 | (4) | (1) | 5 | — | ||||||||||||||||||
| Total | — | % | — | % | 1 | % | 1 | % | (5) | % | — | % | 1 | % | (4) | % | ||||||||||
| Total, excluding the Hydrocarbons & Energy business | — | % | — | % | 2 | % | 2 | % | (5) | % | (1) | % | 3 | % | (3) | % | ||||||||||
| U.S. & Canada | 2 | % | — | % | 3 | % | 5 | % | (4) | % | — | % | 2 | % | (2) | % | ||||||||||
| EMEAI | 2 | — | 3 | 5 | (5) | — | — | (5) | ||||||||||||||||||
| Asia |
Showing the first 8K of 68K characters. Open the full section
Item 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
See Note 19 to the Consolidated Financial Statements and Part II, Item 7A. Quantitative and Qualitative Disclosures About Market Risk in the combined Dow Inc. and TDCC Annual Report on Form 10-K for the year ended December 31, 2023, for information on the Company's utilization of financial instruments and an analysis of the sensitivity of these instruments.
Item 4. CONTROLS AND PROCEDURES
Evaluation of Disclosure Controls and Procedures
As of the end of the period covered by this Quarterly Report on Form 10-Q, Dow Inc. and The Dow Chemical Company (the "Companies") carried out an evaluation, under the supervision and with the participation of the Companies' Disclosure Committee and the Companies' management, including the Chief Executive Officer and the Chief Financial Officer, of the effectiveness of the design and operation of the Companies' disclosure controls and procedures pursuant to paragraph (b) of Exchange Act Rules 13a-15 and 15d-15. Based upon that evaluation, the Chief Executive Officer and the Chief Financial Officer concluded that the Companies' disclosure controls and procedures were effective.
Changes in Internal Control Over Financial Reporting
There were no changes in the Companies' internal control over financial reporting identified in connection with the evaluation required by paragraph (d) of Exchange Act Rules 13a-15 and 15d-15 that was conducted during the quarter ended September 30, 2024, that have materially affected, or are reasonably likely to materially affect, the Companies' internal control over financial reporting.
| Dow Inc. and Subsidiaries The Dow Chemical Company and Subsidiaries PART II – OTHER INFORMATION |
| Item 1. LEGAL PROCEEDINGS |
Asbestos-Related Matters of Union Carbide Corporation
No material developments regarding this matter occurred in the first nine months of 2024. For a current status of this matter, see Note 13 to the Consolidated Financial Statements.
Environmental Proceedings
On December 16, 2022, the U.S. Department of Justice filed a complaint and proposed consent decree on behalf of the U.S. Environmental Protection Agency ("EPA") relating to environmental contamination at the Lower Passaic River Study Area Superfund Site in New Jersey. The EPA filed an amended complaint and proposed consent decree on January 17, 2024. The proposed consent decree includes a requirement that 85 settling defendants, including the Company’s Essex Chemical Corporation subsidiary ("Essex"), make a collective payment of $150 million for the EPA’s past and anticipated future response costs, with Essex's share of the group settlement costs being $1.15 million. On January 31, 2024, the EPA filed a motion for approval and entry of the consent decree.
Item 1A. RISK FACTORS
Since December 31, 2023, there have been no material changes to the Company's Risk Factors.
| Item 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS |
Issuer Purchases of Equity Securities
The following table provides information regarding purchases of Dow Inc. common stock by the Company during the three months ended September 30, 2024:
| Issuer Purchases of Equity Securities | Total number of shares purchased as part of the Company's publicly announced share repurchase program | Approximate dollar value of shares that may yet be purchased under the Company's publicly announced share repurchase program 1 (In millions) | ||||||||||||
| Period | Total number of shares purchased | Average price paid per share | ||||||||||||
| July 2024 | 112,764 | $ | 53.21 | 112,764 | $ | 1,019 | ||||||||
| August 2024 | 1,247,017 | $ | 53.11 | 1,247,017 | $ | 952 | ||||||||
| September 2024 | 419,114 | $ | 51.66 | 419,114 | $ | 931 | ||||||||
| Third quarter 2024 | 1,778,895 | $ | 52.78 | 1,778,895 | $ | 931 |
1.On April 13, 2022, the Dow Inc. Board approved a share repurchase program authorizing up to $3.0 billion for the repurchase of the Company's common stock, with no expiration date.
| Item 4. MINE SAFETY DISCLOSURES |
Not applicable.
Item 5. OTHER INFORMATION
Item 6. EXHIBITS
| EXHIBIT NO. | DESCRIPTION | ||||||||||
| 4.3 | Dow Inc. agrees to provide the SEC, on request, copies of all other such indentures and instruments that define the rights of holders of long-term debt of Dow Inc. and its consolidated subsidiaries, including The Dow Chemical Company, pursuant to Item 601(b)(4)(iii)(A) of Regulation S-K. | ||||||||||
| 23 * | Ankura Consulting Group, LLC's Consent. | ||||||||||
| 31.1 * | Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | ||||||||||
| 31.2 * | Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | ||||||||||
| 32.1 * | Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | ||||||||||
| 32.2 * | Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | ||||||||||
| 101.INS | The instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. | ||||||||||
| 101.SCH | Inline XBRL Taxonomy Extension Schema Document. | ||||||||||
| 101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document. | ||||||||||
| 101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document. | ||||||||||
| 101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document. | ||||||||||
| 101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document. | ||||||||||
| 104 | Cover Page Interactive Data File. The cover page interactive data file does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. |
- Filed herewith
| TRADEMARK LISTING |
The following registered trademark of InspereX Holdings LLC appears in this report: InterNotes®
® ™ Trademark of The Dow Chemical Company ("Dow") or an affiliated company of Dow, except as otherwise specified.
| Dow Inc. and Subsidiaries The Dow Chemical Company and Subsidiaries Signature |
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrants have duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
DOW INC.
THE DOW CHEMICAL COMPANY
Date: October 25, 2024
| /s/ ANDREA L. DOMINOWSKI | ||
| Andrea L. Dominowski Controller and Vice President of Controllers (Authorized Signatory and Principal Accounting Officer) |